/Companies

Anavotx

Leiden, NL · 25 employees on LinkedIn · 4 known investors

Find your way into Anavotx

Sign up to see every warm intro you have to Anavotx

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Anavotx team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Anavo Therapeutics is a biopharmaceutical company using its IGNITE platform to develop phosphatase-targeted allosteric modulators, addressing drug targets previously considered undruggable. It is building a proprietary pipeline of therapeutic programs targeting autoimmune diseases and cancer, with headquarters in Leiden, Netherlands and an R&D hub in Heidelberg, Germany.

Founders & leadership

BZ
Birgit ZechCEOBirgit Zech brings 20 years of biotech industry experience, including 15+ years in business development roles, with expertise in pharmaceutical partnerships, IP management, and small molecule chemistry including kinase inhibitor development.

Investors · 4

Frequently asked questions

What does Anavotx do?
Anavo Therapeutics is a biopharmaceutical company using its IGNITE platform to develop phosphatase-targeted allosteric modulators, addressing drug targets previously considered undruggable. It is building a proprietary pipeline of therapeutic programs targeting autoimmune diseases and cancer, with headquarters in Leiden, Netherlands and an R&D hub in Heidelberg, Germany.
Who are Anavotx's investors?
Anavotx's investors include Taiho Ventures, LLC, Bioqube Ventures, Inkef, M Ventures.
Where is Anavotx headquartered?
Anavotx is headquartered in Leiden, NL.